New insulin meets mystery carb: what happens in type 1 diabetes?
NCT ID NCT07305805
First seen Jan 04, 2026 · Last updated Jun 12, 2026 · Updated 22 times
Summary
This study looked at how a new insulin (NNC0363-1063) interacts with a non-glucose carbohydrate (a type of sugar not used for energy) in 36 adults with type 1 diabetes. Participants received a fixed dose of the insulin and different amounts of the carbohydrate in random order over 4 sessions. The goal was to see if taking them together is safe and how they affect blood sugar control. The study lasted 5 to 12 weeks per person.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS TYPE 1 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Profil Institut für Stoffwechselforschung GmbH
Neuss, 41460, Germany
Conditions
Explore the condition pages connected to this study.